摘要
Under the global pandemic of COVID-19,point-of-care testing(POCT)strategy as a fast,simple,and low-cost biological detection method has drawn much attention for achieving accurate on-site testing[1].
作者
Jimei Chi
Dongdong Wu
Meng Su
Yanlin Song
迟基梅;吴东东;苏萌;宋延林(Key Laboratory of Green Printing,CAS Research/Education Center for Excellence in Molecular Sciences,Institute of Chemistry,Chinese Academy of Sciences,Beijing 100190,China;Beijing Engineering Research Center of Nanomaterials for Green Printing Technology,Beijing National Laboratory for Molecular Sciences,Beijing 100190,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Neurosurgery,First Medical Center,General Hospital of the People’s Liberation Army of China,Beijing 100853,China)
基金
supported by the Beijing Nova Program from Beijing Municipal Science&Technology Commission(Z201100006820037,Z211100002121001)
the National Key Research and Development Program of China(2018YFA0208501)
the National Natural Science Foundation of China(22075296,91963212,and 51961145102)
the Youth Innovation Promotion Association of CAS(2020032)
Beijing National Laboratory for Molecular Sciences(CXXM-202005)。
